Found: 6
Select item for more details and to access through your institution.
Real‐life experience with dimethylfumarate in palmoplantar psoriasis: A multicentre retrospective Italian study.
- Published in:
- Australasian Journal of Dermatology, 2024, v. 65, n. 4, p. e92, doi. 10.1111/ajd.14213
- By:
- Publication type:
- Article
Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5240, doi. 10.3390/jcm13175240
- By:
- Publication type:
- Article
Risk of Skin Cancer in Patients with Psoriasis: Single-Center Retrospective Study Comparing Anti-TNFα and Phototherapy.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2452, doi. 10.3390/jcm13092452
- By:
- Publication type:
- Article
Apremilast in Patients Difficult to Treat: A Multicentric Real-Life Long-Term Experience.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/9775738
- By:
- Publication type:
- Article
Anti‐IL23for nail psoriasis in real life: Results of efficacy and safety during a 52‐week period.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 7, p. 1, doi. 10.1111/dth.15506
- By:
- Publication type:
- Article
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 8, p. e1075, doi. 10.1111/jdv.19117
- By:
- Publication type:
- Article